1. ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p
   Quan Yuan et al, 2020, Cancer Cell International CrossRef
2. CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastoma
   Marcus O. Muench et al, 2023, Frontiers in Oncology CrossRef
3. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma
   Peihang Jing et al, 2016, Experimental and Molecular Pathology CrossRef
4. Retracted: Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA‐122‐5p to regulate ADAM10 expression
   Jun Gao et al, 2019, Journal of Cellular Biochemistry CrossRef
5. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production
   Ga Bin Park et al, 2017, Molecular and Cellular Biochemistry CrossRef
6. Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis
   AmalAbd El Hafez et al, 2023, Indian Journal of Pathology and Microbiology CrossRef
7. Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results
   Katarzyna Walkiewicz et al, 2019, Disease Markers CrossRef
8. ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
   Nathalie Théret et al, 2021, Cancers CrossRef
9. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells
   SONGYANG LIU et al, 2015, Molecular Medicine Reports CrossRef
10. Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
    Ester García-Pras et al, 2021, Cancers CrossRef
11. A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
    Marta Łukaszewicz-Zając et al, 2022, Cancers CrossRef
12. Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113
    YUAN SHAO et al, 2015, Molecular Medicine Reports CrossRef
13. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
    Kwang-Hoon Chun, 2022, Pharmaceutics CrossRef
14. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren V. Owens et al, 2021, Brain Research CrossRef
15. Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma
    Amal A. Mohamed et al, 2021, Current Cancer Therapy Reviews CrossRef
16. Harnessing HEK293 cell-derived exosomes for hsa-miR-365a-3p delivery: Potential application in hepatocellular carcinoma therapy
    Armita Ghotaslou et al, 2024, Heliyon CrossRef
17. Recombinant adeno-associated virus expressing a p53-derived apoptotic peptide (37AA) inhibits HCC cells growth in vitro and in vivo
    Hongyong Zhang et al, 2017, Oncotarget CrossRef
18. Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
    SONGYANG LIU et al, 2014, Oncology Reports CrossRef
19. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
    Petra C. Buchanan et al, 2017, Journal of Biological Chemistry CrossRef
20. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
    Gang Wu et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
21. Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
    Kaku Goto et al, 2018, Oncotarget CrossRef
22. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial–mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10
    Yunxiuxiu Xu et al, 2021, RNA Biology CrossRef